- $694.24m
- $733.01m
- $502.73m
Oncology Institute Inc expected to post a loss of 10 cents a share - Earnings Preview
Brief: Oncology Institute - On June 20, Got Notice From Nasdaq Indicating That Co Is No Longer In Compliance With Nasdaq Listing Rule 5550(A)(2)
Oncology Institute Inc reports results for the quarter ended in March - Earnings Summary
Brief: The Oncology Institute Appoints Jordan McInerney As Chief Development Officer
Oncology Institute Inc reports results for the quarter ended in December - Earnings Summary
Oncology Institute Inc expected to post a loss of 11 cents a share - Earnings Preview
Brief: WellBe Senior Medical Partners With The Oncology Institute To Extend High-Value Cancer Care Services Across Illinois And Ohio
Brief: Havencrest Healthcare Partners Reports Stake Of 12.04% In Oncology Institute As Of Dec 28, 2023
Brief: Oncology Institute Q3 Revenue USD 82 Million
U.S. RESEARCH ROUNDUP- Coeur Mining, FedEx, Uber Technologies
Oncology Institute Inc reports results for the quarter ended in June - Earnings Summary
Brief: Oncology Institute Q2 Revenue USD 80 Million
Oncology Institute Inc expected to post a loss of 17 cents a share - Earnings Preview
Brief: Oncology Institute's Board Approved Share Repurchase Program
U.S. STOCKS ON THE MOVE-Precision Optics, Tesla, airline stocks
U.S. STOCKS ON THE MOVE-Catalent, Marker Therapeutics, Genelux
U.S. STOCKS ON THE MOVE-Chinook Therapeutics, Nasdaq, Carnival Corp
Oncology Institute drops as CEO steps down
U.S. STOCKS ON THE MOVE-Gold miners, ImmunoGen, Oracle